Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WILLIAM E STRICKER

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1902095979
CMS profile
221710
Location
COLUMBIA, MO

General Payments · PY2018–2024

$3,025.57

  • Reported across 155 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$925.09

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $925.09 36

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $298.64 18
PY2019 $194.48 13
PY2020 $220.16 16
PY2021 $320.74 22
PY2022 $475.24 22
PY2023 $591.22 28
PY2024 $925.09 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.98 12/04/2024 Food and Beverage Undisputed 01/23/2026 1106173002 CMS
AstraZeneca Pharmaceuticals LP $36.08 02/06/2024 Food and Beverage Undisputed 01/23/2026 1104725327 CMS
AstraZeneca Pharmaceuticals LP $18.60 03/06/2024 Food and Beverage Undisputed 01/23/2026 1104691084 CMS
AstraZeneca Pharmaceuticals LP $24.68 03/19/2024 Food and Beverage Undisputed 01/23/2026 1105526733 CMS
AstraZeneca Pharmaceuticals LP $22.57 04/01/2024 Food and Beverage Undisputed 01/23/2026 1104589978 CMS
AstraZeneca Pharmaceuticals LP $21.02 05/02/2024 Food and Beverage Undisputed 01/23/2026 1105256056 CMS
AstraZeneca Pharmaceuticals LP $22.22 07/15/2024 Food and Beverage Undisputed 01/23/2026 1105310925 CMS
AstraZeneca Pharmaceuticals LP $17.22 09/11/2024 Food and Beverage Undisputed 01/23/2026 1105657596 CMS
AstraZeneca Pharmaceuticals LP $107.20 10/17/2024 Food and Beverage Undisputed 01/23/2026 1105542717 CMS
AstraZeneca Pharmaceuticals LP $16.25 11/18/2024 Food and Beverage Undisputed 01/23/2026 1104263385 CMS
AstraZeneca Pharmaceuticals LP $18.66 12/06/2024 Food and Beverage Undisputed 01/23/2026 1104729147 CMS
Genentech USA, Inc. $22.96 10/07/2024 Food and Beverage Undisputed 01/23/2026 1133133780 CMS
Genentech USA, Inc. $46.92 10/16/2024 Food and Beverage Undisputed 01/23/2026 1133133788 CMS
Genentech USA, Inc. $23.93 12/09/2024 Food and Beverage Undisputed 01/23/2026 1133133784 CMS
GENZYME CORPORATION $15.69 06/20/2024 Food and Beverage Undisputed 01/23/2026 1139966189 CMS
GENZYME CORPORATION $16.20 08/29/2024 Food and Beverage Undisputed 01/23/2026 1139966211 CMS
GlaxoSmithKline, LLC. $15.09 01/10/2024 Food and Beverage Undisputed 01/23/2026 1116521264 CMS
GlaxoSmithKline, LLC. $16.53 02/28/2024 Food and Beverage Undisputed 01/23/2026 1116656303 CMS
Grifols USA, LLC $15.89 03/07/2024 Food and Beverage Undisputed 01/23/2026 1124747823 CMS
Grifols USA, LLC $107.32 03/19/2024 Food and Beverage Undisputed 01/23/2026 1124747821 CMS
Grifols USA, LLC $19.17 07/22/2024 Food and Beverage Undisputed 01/23/2026 1124747825 CMS
Grifols USA, LLC $16.57 12/10/2024 Food and Beverage Undisputed 01/23/2026 1124747827 CMS
Novartis Pharmaceuticals Corporation $18.15 01/17/2024 Food and Beverage Undisputed 01/23/2026 1087260107 CMS
Optinose US, Inc. $20.00 04/17/2024 Food and Beverage Undisputed 01/23/2026 1142181906 CMS
Optinose US, Inc. $21.17 08/12/2024 Food and Beverage Undisputed 01/23/2026 1142181936 CMS
Optinose US, Inc. $15.01 10/17/2024 Food and Beverage Undisputed 01/23/2026 1142181926 CMS
Regeneron Healthcare Solutions, Inc. $19.60 01/25/2024 Food and Beverage Undisputed 01/23/2026 1114199657 CMS
Regeneron Healthcare Solutions, Inc. $20.20 03/11/2024 Food and Beverage Undisputed 01/23/2026 1114199663 CMS
Regeneron Healthcare Solutions, Inc. $30.56 04/29/2024 Food and Beverage Undisputed 01/23/2026 1114199669 CMS
Regeneron Healthcare Solutions, Inc. $17.81 05/01/2024 Food and Beverage Undisputed 01/23/2026 1114199676 CMS
Regeneron Healthcare Solutions, Inc. $19.54 08/15/2024 Food and Beverage Undisputed 01/23/2026 1114199682 CMS
Regeneron Healthcare Solutions, Inc. $32.33 09/17/2024 Food and Beverage Undisputed 01/23/2026 1114199689 CMS
Regeneron Healthcare Solutions, Inc. $20.28 10/17/2024 Food and Beverage Undisputed 01/23/2026 1114199696 CMS
Regeneron Healthcare Solutions, Inc. $16.88 12/12/2024 Food and Beverage Undisputed 01/23/2026 1114199703 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.04 08/08/2024 Food and Beverage Undisputed 01/23/2026 1137683065 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.77 09/26/2024 Food and Beverage Undisputed 01/23/2026 1137683067 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.